Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018

NCT04681417 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT04681417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04681417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Lead sponsor
Institut Curie
Phase
Phase 2/3
Overall status
Recruiting
Start date
March 25, 2021
Completion date
January 20, 2036
Enrollment
225 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

retinoblastoma